Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/1999
10/14/1999CA2327706A1 Methods for inhibiting mrp1
10/14/1999CA2327617A1 Methods for inhibiting mrp1
10/14/1999CA2327452A1 Methods for inhibiting mrp1
10/14/1999CA2327279A1 Calcilytic compounds
10/14/1999CA2327185A1 Pyrazole inhibitors of cytokine production
10/14/1999CA2327095A1 Compositions containing a combination of a creatine compound and a second agent
10/14/1999CA2326884A1 Thiazolo¬4,5-d|pyrimidines and pyridines as corticotropin releasing factor (crf) antagonists
10/14/1999CA2326759A1 Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
10/14/1999CA2326739A1 Methods for enhancing antigen-presenting cells and anti-tumor responses in a human patient
10/14/1999CA2326606A1 Aminoalkyl substituted 9h-pyridino¬2,3-b|indole and 9h-pyrimidino¬4,5-b|indole derivatives:crf1 and npy1 receptors
10/14/1999CA2326522A1 Pyrrolo¬1,2-a|pyrazine spla2 inhibitor
10/14/1999CA2326507A1 Methods and compositions for reducing uv-induced inhibition of collagen synthesis in human skin
10/14/1999CA2326383A1 Aminoalkyl substituted pyrrolo¬2,3-b|pyridine and pyrrolo¬2,3-d|pyrimidine derivatives: modulators of crf1 receptors
10/14/1999CA2326184A1 Antagonists of gonadotropin releasing hormone
10/14/1999CA2326146A1 Template associated npy y2-receptor agonists
10/14/1999CA2326140A1 Antagonists of gonadotropin releasing hormone
10/14/1999CA2325342A1 Dual avb3 and metastasis-associated receptor ligands
10/14/1999CA2325007A1 Human galactosyl transferases
10/14/1999CA2324983A1 Hiv-specific cytotoxic t-cell responses
10/14/1999CA2324976A1 Inhibition of binding of hox and homeodomain-containing proteins and uses thereof
10/14/1999CA2317572A1 Pharmaceutical compositions and methods for use
10/14/1999CA2317570A1 Pharmaceutical compositions and methods of use
10/14/1999CA2317567A1 Pharmaceutical compositions and methods for use
10/13/1999EP0949250A1 Process for manufacturing alpha1L-adrenoceptor antagonists
10/13/1999EP0949245A1 Process for alkylating hindered sulfonamides
10/13/1999EP0948651A1 Recombinant n-smases and nucleic acids encoding same
10/13/1999EP0948620A2 Secreted proteins and polynucleotides encoding them
10/13/1999EP0948616A2 Riboflavin mutants as vaccines against actinobacillus pleuropneumoniae
10/13/1999EP0948597A1 HUMAN MUCOSAL ADDRESSIN CELL ADHESION MOLECULE-1 (MAdCAM-1) AND SPLICE VARIANTS THEREOF
10/13/1999EP0948545A1 Antibodies specifically recognising a nitrosylated protein, method of preparation, therapeutic and diagnostic use
10/13/1999EP0948541A2 Analogs of parathyroid hormone
10/13/1999EP0948539A2 Peptides and compounds that bind to a receptor
10/13/1999EP0948524A1 Peptides agonists of bradykinine b 2? receptor
10/13/1999EP0948522A1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines
10/13/1999EP0948520A1 Tissue specific expression of retinoblastoma protein
10/13/1999EP0948515A1 Human b-cell translocation genes-2 and 3
10/13/1999EP0948510A1 Immunostimulatory nucleic acid molecules
10/13/1999EP0948500A1 Cyclic organoselenium compounds, their preparation and their uses
10/13/1999EP0948489A1 Piperazine compounds as inhibitors of mmp or tnf
10/13/1999EP0948483A1 Farnesyl transferase inhibitors
10/13/1999EP0948478A1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO 1,2-g]-CHROM-3-ENE, BENZO 1,2-g]-THIOCHROM-3-ENE AND BENZO 1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY
10/13/1999EP0948358A1 Stable liquid interferon formulations
10/13/1999EP0948349A1 Treatment of inner ear hair cells
10/13/1999EP0948348A1 Manipulation of non-terminally differentiated cells using the notch pathway
10/13/1999EP0948345A1 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction
10/13/1999EP0948341A1 Phospholipid drug derivatives
10/13/1999EP0948340A1 Biologically active substances, method for obtaining and compositions containing them
10/13/1999EP0948335A1 Methods of treating or preventing cardiac arrhythmia
10/13/1999EP0948330A1 Il-8 receptor antagonists
10/13/1999EP0948308A1 Methods for treating skin pigmentation
10/13/1999EP0948257A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
10/13/1999EP0936912A4 Inhibitors of cysteine protease
10/13/1999EP0783486B1 Novel prostaglandin synthase inhibitors
10/13/1999EP0740654B1 Monoamine oxidase b inhibitors, processes for their preparation and use thereof
10/13/1999EP0710233B1 Heteroaryl cycloalkenyl hydroxyureas
10/13/1999EP0668854B1 Use of n-arylmethylene, ethylenediaminetriacetates n-arylmethylene iminodiacetates or n,n'-diarylmethylene ethylenediaminacetates for use in combatting oxidative stress
10/13/1999EP0579618B1 Pyridine- and imidazole-derived agents for cardiovascular diseases
10/13/1999EP0574457B1 Antiviral nucleoside combination
10/13/1999CN1231666A Tricyclic benzazepine vasopressin antagonists
10/13/1999CN1231664A Sulfonamicles and derivatives thereof that moulate the activity of endothelin
10/13/1999CN1231662A Quinazoline derivatives and pharmaceutical compositions containing them
10/13/1999CN1231661A Aralkyl and aralkylidene heterocyclic lactams and imides
10/13/1999CN1231608A Use of PKC inhibitors for the manufacture of a medicament for the treatment of HTLV-1 infections
10/13/1999CN1231607A Use of inhibitors of PKG for the manufacture of a medicament for the treatment of central nervous system diseases associated with HIV infection
10/13/1999CN1231287A Benzosulfone derivatives
10/13/1999CN1231201A Compound donkey-hide gelatin preparation for preventing arrest of bone marrow in chemotherapy and radiotherapy and preparing process thereof
10/13/1999CN1231176A Method for treating heart failure
10/13/1999CN1045602C Tetrahydropyrido-indole derivant and medicinal composition and pharmaceutical use thereof
10/13/1999CN1045601C Novel quinuclidine derivatives and medicinal composition thereof
10/13/1999CN1045596C Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action
10/12/1999US5965763 Biphenyl compounds
10/12/1999US5965745 Asthma; antiarthritic,-shock agents; bronchitis; respiratory system diseases, e.g. chronic obstructive airways diseases; psoriasis; allergic rhinitis; atopic dermatitis
10/12/1999US5965744 Ortho-substituted benzoylguanidines, including composition and methods of using them
10/12/1999US5965732 Sulfonamide endothelin antagonists
10/12/1999US5965728 Process for the preparation of a salt clavulanic acid
10/12/1999US5965724 GP 130 lacking the transmembrane domain
10/12/1999US5965720 With sequence complementary to messenger rna from a gene selected from the group consisting of c-myc, c-myb, c-fos, c-kit, ras and bcr/abl; antisense/anticarcinogenic agents
10/12/1999US5965718 Analogs of sarcodictyin and eleutherobin
10/12/1999US5965711 A protein; anticarcinogenic/antiarthritic/antidiabetic agents; treatment of addison's and crohn's disease, multiple sclerosis, scleroderma, ulcers, respiratory disorders; fungicides, viricides, bactericides
10/12/1999US5965703 Bcl-x/bcl-2 associated death polypeptide; used for regulating apoptosis in treating acquired immune deficiency syndrome and neurodegenerative diseases; antiischemic agents
10/12/1999US5965693 Isolated polynucleotides; diagnosis and treatment of autoimmune diseases, tissue rejection, allergies, acquired immune deficiency disorder, viricides, bactericides, fungicides and anticarcinogenic agents
10/12/1999US5965692 Anticoagulants for treatment of thromobosis and hypercoagulability in blood and tissues
10/12/1999US5965601 Novel compounds for inhibiting replication of a retrovirus; treating hiv
10/12/1999US5965586 Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation
10/12/1999US5965585 Suppressing formation of collagen and collagen-like substances or biosynthesis of procollagen in living systems by administering a hydroxypyridone compound enzyme inhibitor of protein hydroxylase; antiscarring agents
10/12/1999US5965584 Pharmaceutical composition
10/12/1999US5965583 Substituted imidazoles useful in the treatment of inflammatory disease
10/12/1999US5965582 Antihistamines
10/12/1999US5965580 Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
10/12/1999US5965579 Antagonists of the neurotensin receptors; increasing affinity for human neurotensin receptors
10/12/1999US5965564 Enantiomerically pure hydroxylated xanthine compounds
10/12/1999US5965563 Aryl and heteroaryl purine compounds
10/12/1999US5965562 Treating disorders induced by substance p and migraine headache
10/12/1999US5965553 Anticholesterol agents, hypotriglyceridemic agents, antiatherosclerosis agents, antifungal agents, alzheimer's agents or anti-acne agents
10/12/1999US5965548 For treatment of prostatic cancer, breast cancer
10/12/1999US5965547 Inhibiting bone resorption, use for joint replacement, especially hip replacement in man
10/12/1999US5965416 Arginyl tRNA synthetase from staphyloccus aureus
10/12/1999US5965403 Nucleic acids encoding bone morphogenic protein-16 (BMP-16)
10/12/1999US5965396 Human lymph node derived GTPase
10/12/1999US5965386 Yeast strains and modified albumins
1 ... 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 ... 1564